Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker

Juzar S. Kaka, Khalil Al-Khamis, Musbah O M Tanira

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pharmacokinetics of tolbutamide (TB) have been studied in endotoxin pretreated rats with the aim of evaluating TB as a marker for endotoxin effects. Endotoxin dose of 10 mg/kg resulted in a 50% rate of mortality. TB was i.v. administered 24 h. after endotoxin dosing. Clearance (CI) decreased by approximately 2/3 of its value, area under the curve (AUC) and half-life (t1/2) in the pretreated animals were an average 1.5 times the values for the respective controls. Volume of distribution (Vd) increased by 10% approximately. These findings suggest that endotoxin pretreatment may cause hepatic damage by producing a decrease in Cl and an increase in the t1/2 of TB. But, SGOT levels in pretreated animals were no significantly different. This phenomenon may be explained by the increase in plasma protein binding of TB during endotoxin pretreatment, which decreases the free fraction of the drug in plasma available for metabolism. Endotoxin increased tmax of hydroxy-TB, while no change in Cmax was observed. Since tmax is inversely related to the formation and elimination rates of hydroxy-TB1 an increase in tmax may be due to the decrease in both elimination rates. No change in Cmax may be due to the decrease in the rate of formation which is equivalent to the decrease in the rate of elimination of hydroxy-TB.

Original languageEnglish
Pages (from-to)203-209
Number of pages7
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Volume15
Issue number3
DOIs
Publication statusPublished - Jul 1990

Fingerprint

Tolbutamide
Endotoxins
Liver
Aspartate Aminotransferases
Protein Binding
Area Under Curve
Half-Life
Blood Proteins
Pharmacokinetics
Mortality
Pharmaceutical Preparations

Keywords

  • endotoxin
  • hepatic dysfunction
  • rats
  • Tolbutamide

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Medicine(all)

Cite this

Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker. / Kaka, Juzar S.; Al-Khamis, Khalil; Tanira, Musbah O M.

In: European Journal of Drug Metabolism and Pharmacokinetics, Vol. 15, No. 3, 07.1990, p. 203-209.

Research output: Contribution to journalArticle

@article{7aba80f7a659426c89c1314a5ad8115d,
title = "Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker",
abstract = "The pharmacokinetics of tolbutamide (TB) have been studied in endotoxin pretreated rats with the aim of evaluating TB as a marker for endotoxin effects. Endotoxin dose of 10 mg/kg resulted in a 50{\%} rate of mortality. TB was i.v. administered 24 h. after endotoxin dosing. Clearance (CI) decreased by approximately 2/3 of its value, area under the curve (AUC) and half-life (t1/2) in the pretreated animals were an average 1.5 times the values for the respective controls. Volume of distribution (Vd) increased by 10{\%} approximately. These findings suggest that endotoxin pretreatment may cause hepatic damage by producing a decrease in Cl and an increase in the t1/2 of TB. But, SGOT levels in pretreated animals were no significantly different. This phenomenon may be explained by the increase in plasma protein binding of TB during endotoxin pretreatment, which decreases the free fraction of the drug in plasma available for metabolism. Endotoxin increased tmax of hydroxy-TB, while no change in Cmax was observed. Since tmax is inversely related to the formation and elimination rates of hydroxy-TB1 an increase in tmax may be due to the decrease in both elimination rates. No change in Cmax may be due to the decrease in the rate of formation which is equivalent to the decrease in the rate of elimination of hydroxy-TB.",
keywords = "endotoxin, hepatic dysfunction, rats, Tolbutamide",
author = "Kaka, {Juzar S.} and Khalil Al-Khamis and Tanira, {Musbah O M}",
year = "1990",
month = "7",
doi = "10.1007/BF03190205",
language = "English",
volume = "15",
pages = "203--209",
journal = "European Journal of Drug Metabolism and Pharmacokinetics",
issn = "0378-7966",
publisher = "Springer Paris",
number = "3",

}

TY - JOUR

T1 - Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker

AU - Kaka, Juzar S.

AU - Al-Khamis, Khalil

AU - Tanira, Musbah O M

PY - 1990/7

Y1 - 1990/7

N2 - The pharmacokinetics of tolbutamide (TB) have been studied in endotoxin pretreated rats with the aim of evaluating TB as a marker for endotoxin effects. Endotoxin dose of 10 mg/kg resulted in a 50% rate of mortality. TB was i.v. administered 24 h. after endotoxin dosing. Clearance (CI) decreased by approximately 2/3 of its value, area under the curve (AUC) and half-life (t1/2) in the pretreated animals were an average 1.5 times the values for the respective controls. Volume of distribution (Vd) increased by 10% approximately. These findings suggest that endotoxin pretreatment may cause hepatic damage by producing a decrease in Cl and an increase in the t1/2 of TB. But, SGOT levels in pretreated animals were no significantly different. This phenomenon may be explained by the increase in plasma protein binding of TB during endotoxin pretreatment, which decreases the free fraction of the drug in plasma available for metabolism. Endotoxin increased tmax of hydroxy-TB, while no change in Cmax was observed. Since tmax is inversely related to the formation and elimination rates of hydroxy-TB1 an increase in tmax may be due to the decrease in both elimination rates. No change in Cmax may be due to the decrease in the rate of formation which is equivalent to the decrease in the rate of elimination of hydroxy-TB.

AB - The pharmacokinetics of tolbutamide (TB) have been studied in endotoxin pretreated rats with the aim of evaluating TB as a marker for endotoxin effects. Endotoxin dose of 10 mg/kg resulted in a 50% rate of mortality. TB was i.v. administered 24 h. after endotoxin dosing. Clearance (CI) decreased by approximately 2/3 of its value, area under the curve (AUC) and half-life (t1/2) in the pretreated animals were an average 1.5 times the values for the respective controls. Volume of distribution (Vd) increased by 10% approximately. These findings suggest that endotoxin pretreatment may cause hepatic damage by producing a decrease in Cl and an increase in the t1/2 of TB. But, SGOT levels in pretreated animals were no significantly different. This phenomenon may be explained by the increase in plasma protein binding of TB during endotoxin pretreatment, which decreases the free fraction of the drug in plasma available for metabolism. Endotoxin increased tmax of hydroxy-TB, while no change in Cmax was observed. Since tmax is inversely related to the formation and elimination rates of hydroxy-TB1 an increase in tmax may be due to the decrease in both elimination rates. No change in Cmax may be due to the decrease in the rate of formation which is equivalent to the decrease in the rate of elimination of hydroxy-TB.

KW - endotoxin

KW - hepatic dysfunction

KW - rats

KW - Tolbutamide

UR - http://www.scopus.com/inward/record.url?scp=0025196884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025196884&partnerID=8YFLogxK

U2 - 10.1007/BF03190205

DO - 10.1007/BF03190205

M3 - Article

VL - 15

SP - 203

EP - 209

JO - European Journal of Drug Metabolism and Pharmacokinetics

JF - European Journal of Drug Metabolism and Pharmacokinetics

SN - 0378-7966

IS - 3

ER -